S

Shanghai Wanye Enterprises Co Ltd
SSE:600641

Watchlist Manager
Shanghai Wanye Enterprises Co Ltd
SSE:600641
Watchlist
Price: 15.66 CNY -2.43% Market Closed
Market Cap: 14.3B CNY
Have any thoughts about
Shanghai Wanye Enterprises Co Ltd?
Write Note
Shanghai Wanye Enterprises Co Ltd
/
Income Statement
/
Cost of Revenue

Shanghai Wanye Enterprises Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai Wanye Enterprises Co Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
Shanghai Wanye Enterprises Co Ltd
SSE:600641
Cost of Revenue
-¥301.3m
CAGR 3-Years
18%
CAGR 5-Years
23%
CAGR 10-Years
14%
Longfor Group Holdings Ltd
HKEX:960
Cost of Revenue
-¥139.2B
CAGR 3-Years
0%
CAGR 5-Years
-10%
CAGR 10-Years
-16%
China Vanke Co Ltd
SZSE:000002
Cost of Revenue
-¥373.5B
CAGR 3-Years
-1%
CAGR 5-Years
-9%
CAGR 10-Years
-13%
Poly Developments and Holdings Group Co Ltd
SSE:600048
Cost of Revenue
-¥297.8B
CAGR 3-Years
-14%
CAGR 5-Years
-14%
CAGR 10-Years
-14%
Y
Youngor Group Co Ltd
SSE:600177
Cost of Revenue
-¥9.4B
CAGR 3-Years
-18%
CAGR 5-Years
-11%
CAGR 10-Years
0%
China Merchants Shekou Industrial Zone Holdings Co Ltd
SZSE:001979
Cost of Revenue
-¥162.4B
CAGR 3-Years
-8%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
No Stocks Found

Shanghai Wanye Enterprises Co Ltd
Glance View

Market Cap
14.5B CNY
Industry
Real Estate

Shanghai Wanye Enterprises Co Ltd has traversed an intriguing journey from its origins, evolving into a dynamic player in several sectors. Rooted in the bustling metropolis of Shanghai, the company navigates multiple industries with a focus on real estate, biotechnology, and high-tech investments. Over the years, Wanye has astutely recognized the potential in blending traditional real estate ventures with new-age biotech innovations. Its real estate arm concentrates primarily on the development and management of commercial and residential properties, leveraging its deep understanding of urban landscapes to maximize asset value. Meanwhile, its interest in biotechnology represents a strategic pivot towards high-growth sectors, signifying an alignment with global trends in health and science innovations. Money-making for Wanye Enterprises involves a sophisticated balance of developing high-demand real estate projects and acquiring stakes in promising biotech start-ups and technological ventures. This dual approach not only diversifies its revenue streams but also mitigates risks associated with market fluctuations in single sectors. The company's real estate segment generates consistent cash flow through property sales and rental income, underwriting its forays into the less predictable biotech sector. Meanwhile, investments in technology and biotechnology hold the potential for substantial returns, underpinning growth through innovations that could revolutionize industries. Through strategic investment, development expertise, and market adaptability, Shanghai Wanye Enterprises Co Ltd effectively harnesses various economic waves, positioning itself as a resilient business entity in China's rapidly evolving economic landscape.

Intrinsic Value
8.34 CNY
Overvaluation 47%
Intrinsic Value
Price
S
What is Intrinsic Value?

See Also

What is Shanghai Wanye Enterprises Co Ltd's Cost of Revenue?
Cost of Revenue
-301.3m CNY

Based on the financial report for Sep 30, 2024, Shanghai Wanye Enterprises Co Ltd's Cost of Revenue amounts to -301.3m CNY.

What is Shanghai Wanye Enterprises Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
14%

Over the last year, the Cost of Revenue growth was 66%. The average annual Cost of Revenue growth rates for Shanghai Wanye Enterprises Co Ltd have been 18% over the past three years , 23% over the past five years , and 14% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.